Andrew Luck a NFL legend in the making

10 January 2015

Sooner than it gets lost and, Without a doubt, How can you ever overlook a 28 point comeback win in a playoff game, Regardless? In what will be next, It time to reflect on what Andrew Luck has been able to do in less than two years in a town Peyton Manning used to own. […]

Continue Reading

Visterra Closes $30 Million Series B Financing – Co-led by New Investors, Merck Research Labs Venture Fund, Vertex Venture Holdings and Temasek

02 October 2014

Cambridge, MA – October 2, 2014 Visterra, Inc., a biotechnology company that uses its proprietary technology platform to identify unique disease targets and design novel therapeutics, today announced that it has completed a $30 million Series B financing round. The proceeds will be used to advance the development of multiple product candidates from the company’s […]

Continue Reading

Holaira Named FierceMedicalDevices’ 2014 Fierce 15

01 October 2014

The scoop: Drug options for chronic obstructive pulmonary disease (COPD) are only modestly effective. Holaira is betting that its lung denervation device can improve COPD treatment, either as a replacement for drugs or in addition to them. COPD is characterized by persistent airflow limitation caused by progressive narrowing of the airways. This leads to shortness […]

Continue Reading

Holaira Closes $42 Million Round – Investment led by Vertex Venture Holdings to Support Randomized Clinical Trial

03 April 2014

Minneapolis, MN, April 03, 2014 – Holaira, Inc., a developer of medical devices to treat obstructive lung diseases, today announced the completion of its Series D private equity financing, totaling $42 million led by Vertex Venture Holdings Ltd. Other participants in this financing round include Windham Venture Partners, two strategic investors, and all of Holaira’s […]

Continue Reading

Ivantis Completes a $46.5 MM Financing; Company Receives Approval to Expand US Pivotal Trial for Novel Glaucoma Device

13 January 2014

One of the largest medical device financings of the past year in the US; funds will support multiple clinical trials, including recently expanded US pivotal trial for novel glaucoma device IRVINE, Calif.–(BUSINESS WIRE)–Ivantis, developer of the novel Hydrus® Microstent device designed to lower eye pressure for glaucoma patients, announced today that it secured an additional […]

Continue Reading